Showing results (2181-2190 of 2,931) with videos related to
Sort By:
Pageof 294
Pediatric Quality & Safety|April 4, 2024
Reduction of Very Rapid Emergency Transfers to the Pediatric Intensive Care UnitStacy E Kuehn, Jennifer E Melvin, Pamela S Creech, et al.Langmuir : the ACS Journal of Surfaces and Colloids|May 10, 2012
Inclusion properties of volatile organic compounds in a calixarene-based organic zeoliteLoredana Erra, Consiglia Tedesco, Ivano Immediata, et al.The Journal of Clinical Endocrinology and Metabolism|June 19, 2015
RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected PatientsSuman Srinivasa, Kathleen V Fitch, Kimberly Wong, et al.Biochemistry|January 29, 2003
Heterologous production of Halorhodospira halophila holo-photoactive yellow protein through tandem expression of the postulated biosynthetic genesJohn A Kyndt, Frank Vanrobaeys, John C Fitch, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
A murine CD4-, CD8- T cell receptor-gamma delta T lymphocyte clone specific for herpes simplex virus glycoprotein IR M Johnson, D W Lancki, A I Sperling, et al.Supportive Cancer Therapy|July 17, 2008
Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology programCleveland G Shields, Gary R Morrow, Jennifer Griggs, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalitiesTisha Joy, Hester M Keogh, Colleen Hadigan, et al.The American Journal of Pathology|June 24, 2005
EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injuryLuisa Campagnolo, Amy Leahy, Smita Chitnis, et al.Current Oncology (Toronto, Ont.)|May 12, 2017
Challenges and insights in implementing coordinated care between oncology and primary care providers: a Canadian perspectiveJ R Tomasone, M Vukmirovic, M C Brouwers, et al.Allergy|October 3, 2009
Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthmaA Tomkinson, J Tepper, M Morton, et al.Pageof 294